Matrixyl vs Argireline

Side by side

Matrixyl Medium and Argireline Medium are the two peptides most often paired on anti-wrinkle labels ¹. The table is read from our encyclopedia entries.

Opposite approaches to the same line

Fine lines and expression lines have different causes. Fine lines come largely from thinning, less elastic skin as collagen declines with age and sun exposure. Expression lines, such as crow's feet and frown lines, are creased in by repeated muscle movement.

Matrixyl targets the first. Its five-amino-acid core, Lys-Thr-Thr-Lys-Ser, is a fragment of type I procollagen that stimulated fibroblasts to make more extracellular matrix in a 1993 cell study (cell study) ²; a fatty acid is attached to help it into skin. Argireline targets the second. It copies the start of SNAP-25, a protein nerve endings need to release acetylcholine, and in its developers' laboratory work it interfered with that release, far more weakly than botulinum toxin (laboratory and volunteer study) ³.

The one head-to-head trial

A 2023 double-blind trial in Indonesia randomised 21 women aged 26 to 55 with crow's feet to a palmitoyl pentapeptide-4 cream, an acetyl hexapeptide-3 cream (acetyl hexapeptide-3 is another name for Argireline) or placebo, applied twice daily to the eye area for eight weeks. Measurements included hydration, water loss, elasticity, photographs and a crow's-feet grading scale. The authors concluded that the Matrixyl cream gave better results than both the Argireline cream and placebo (randomised trial) ⁴.

It is a useful result but a fragile one: about seven women per group, eight weeks, one population, and the authors themselves call it an initial study needing more subjects and a longer duration. Crow's feet are expression lines, Argireline's home ground, which makes the result more interesting, but not enough to settle the question.

Each one's own evidence

Matrixyl's strongest trial is the 2005 split-face study in 93 women aged 35 to 55: 12 weeks of moisturiser with 3 ppm pal-KTTKS on one side and the same moisturiser without it on the other, with significantly greater reduction in wrinkles and fine lines on the peptide side by image analysis and expert grading (randomised trial) ⁵.

Argireline's include its developers' 2002 volunteer study, where a 10% emulsion reduced wrinkle depth by up to 30% over 30 days (volunteer study) ³, and a 2013 randomised trial in 60 Chinese adults where four weeks of twice-daily application around the eyes gave 48.9% global improvement against 0% with placebo (randomised trial) ⁶. Both sets of trials are short, most are small, and some were run or funded by companies that sell the ingredient.

Getting through the skin

Neither peptide can work if it stays on the surface. For Argireline, the measurement exists: in human cadaver skin, a 10% emulsion left most of the peptide on the surface, about 0.01% of the dose in the epidermis and none in the dermis, where its target nerves are (laboratory study) ⁷. For Matrixyl, a lab comparison found the palmitoylated form crossed skin better than plain KTTKS, which is the point of the fatty acid (laboratory study) ⁸. Matrixyl's target, the fibroblast, also sits closer to the surface than Argireline's nerve endings do, which may be part of why a collagen signal is easier to deliver than a muscle relaxer.

Safety and status

Both are sold as cosmetic ingredients in the US, which need no FDA approval and are not reviewed for effectiveness ⁹. The US Cosmetic Ingredient Review panel concluded in 2025 that Argireline is safe at concentrations up to 0.005% and that the data are insufficient above that (safety assessment) ¹⁰. Matrixyl's trial concentration was 3 ppm, or 0.0003% ⁵. Neither trial reported meaningful irritation. Many products combine the two; no published trial has tested a combination against either alone.

Questions to ask before you buy

• Are your lines mostly fine lines, or expression lines that deepen when you move your face?
• Does the product state its peptide concentrations?
• Is it being sold as a replacement for sunscreen or a retinoid, which have much stronger evidence?

How the differences add up (as of October 4, 2026)

Matrixyl and Argireline work on different causes of wrinkles. Each has a positive placebo-controlled trial of its own, and the only direct comparison, a small eight-week trial in crow's feet, favoured Matrixyl. Argireline's main limitation is delivery: very little of it reaches the depth of its target. Both are cosmetic ingredients with modest, short-term evidence.

Frequently asked questions

Is Matrixyl or Argireline better?

In the one direct comparison, a randomised trial in 21 women with crow's feet, the Matrixyl cream gave better results than the Argireline cream and placebo. It was a small, short study.

How do Matrixyl and Argireline work differently?

Matrixyl is a procollagen fragment meant to signal skin cells to make collagen. Argireline is a nerve-protein fragment meant to reduce muscle contraction behind expression lines.

Can I use Matrixyl and Argireline together?

Many products do, but no published trial has tested the combination.

Is Argireline safe?

The US Cosmetic Ingredient Review panel found it safe in cosmetics up to 0.005% and the data insufficient above that.

Are they FDA-approved?

No. Both are cosmetic ingredients, which do not need FDA approval.

Related on Grey Peptides

• Matrixyl
• Argireline
• GHK-Cu vs Matrixyl
• Argireline vs SNAP-8

Sources

1. Grey Peptides dataset records for Matrixyl (palmitoyl pentapeptide-4, Pal-Lys-Thr-Thr-Lys-Ser, C39H75N7O10, 802.07 g/mol) and Argireline (acetyl hexapeptide-8, Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2, C34H60N14O12S, 888.98 g/mol), both cosmetic ingredients with evidence level medium; read October 4, 2026.
2. Katayama, K., et al. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem, 268(14), 9941-4. PMID: 8486721
3. Blanes-Mira, C., et al. (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci, 24(5), 303-10. PMID: 18498523
4. Aruan, R. R., et al. (2023). Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet. J Clin Aesthet Dermatol, 16(2), 37-43. PMID: 36909866
5. Robinson, L. R., et al. (2005). Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci, 27(3), 155-60. PMID: 18492182
6. Wang, Y., et al. (2013). The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol, 14(2), 147-53. PMID: 23417317
7. Kraeling, M. E., et al. (2015). In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutan Ocul Toxicol, 34(1), 46-52. PMID: 24754410
8. Choi, Y. L., et al. (2014). Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS). Biomol Ther (Seoul), 22(4), 321-7. PMID: 25143811
9. U.S. Food and Drug Administration. FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated. Read October 4, 2026. Source
10. Johnson, W., Jr., et al. (2025). Safety Assessment of Acetyl Hexapeptide-8 Amide as Used in Cosmetics. Int J Toxicol, 44(2_suppl), 54S-63S. PMID: 40673537

Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.